Medi-Tech Insights Get in touch

Global Oral Drug Delivery Technology Market Size & Trends Report Segmented by Dosage Form (Solid, Tablets, Capsules, Liquid, Gels), Delivery (Conventional, Controlled-release), Application (Oncology, CVDs, GI, CNS), End-user (Hospitals/Clinics, ASCs), & Regional Forecast to 2031

Request Quote Download FREE Sample
Single User

Table of Contents

  1. Introduction
    • Introduction
    • Market Scope
      • Market Definition
      • Segments Covered
      • Regional Segmentation
    • Research Timeframe
    • Currency Considered
    • Study Limitations
    • Stakeholders
    • List of Abbreviations
    • Key Conferences and Events (2026-2027)
  2. Research Methodology
    • Secondary Research
    • Primary Research
    • Market Estimation
      • Bottom-Up Approach
      • Top-Down Approach
    • Market Forecasting
  3. Executive Summary
    • Oral Drug Delivery Technology Market Snapshot (2026-2031)
    • Segment Overview
    • Regional Snapshot
    • Competitive In"4">
    • Market Overview
      • Market Dynamics
        • Drivers
          • High patient compliance, convenience, and non-invasive nature
          • Rising prevalence of chronic diseases requiring long-term therapy
          • Growth in novel drug molecules
          • Technological advancements in controlled and targeted drug delivery
          • Cost advantages compared with injectable drug delivery
        • Restraints
          • Limitations in oral bioavailability due to GI barriers
          • Limited site-specific targeting with conventional oral systems
          • Manufacturing and scalability challenges
          • Regulatory and safety concerns
        • Opportunities
          • Development of oral biologics and peptide delivery systems
          • Nanotechnology-based oral drug delivery systems
          • Growth in personalized medicine and precision dosing
          • Increasing development of oral vaccines
        • Key Market Trends
            li>Growth of oral thin films and fast-dissolving tablets
          • Expansion of lipid-based drug delivery systems
          • Use of AI and advanced formulation modelling
        • Unmet Market Needs
        • Industry Speaks
  1. Global Oral Drug Delivery Technology Market Size & Forecast (2024-2031), By Dosage Form, USD Billion
    • Introduction
    • Solid Oral Dosage Forms
      • Tablets
      • Capsules
      • Powders and Granules
      • Other Solid Oral Dosage Forms
    • Liquid Oral Dosage Forms
      • Syrups
      • Suspensions
      • Solutions
      • Other Liquid Oral Dosage Forms
    • Semi-solid Oral Dosage Forms
      • Oral Gels
      • Oral Pastes
    • Other Dosage Forms
  2. Global Oral Drug Delivery Technology Market Size & Forecast (2024-2031), By Delivery Type, USD Billion
    • Introduction
    • Conventional Drug Delivery
    • Controlled-release Drug Delivery
    • Other Delivery Types
  3. Global Oral Drug Delivery Technology Market Size & Forecast (2024-2031), By Therapeutic Application, USD Billion
    • Introduction
    • Oncology
    • Cardiovascular Diseases (CVDs)
    • Diabetes
    • Central Nervous System (CNS) Disorders
    • Gastrointestinal (GI) Disorders
    • Infectious Diseases
    • Respiratory Diseases
    • Autoimmune Diseases
    • Other Therapeutic Applications
  4. Global Oral Drug Delivery Technology Market Size & Forecast (2024-2031), By End User, USD Billion
    • Introduction
    • Hospitals & Clinics
    • Ambulatory Surgical Centers (ASCs)
    • Home Care Settings
    • Other End Users
  5. Global Oral Drug Delivery Technology Market Size & Forecast (2024-2031), By Region, USD Billion
    • Introduction
    • North America Delivery Technology Market Size & Forecast (2024-2031), By Country, USD Billion
      • US
        • Market Size & Forecast, By Dosage Form, (USD Billion)
        • Market Size & Forecast, By Delivery Type (USD Billion)
        • Market Size & Forecast, By Therapeutic Application (USD Billion)
        • Market Size & Forecast, By End User (USD Billion)
      • Canada
        • Market Size & Forecast, By Dosage Form, (USD Billion)
        • Market Size & Forecast, By Delivery Type (USD Billion)
        • Market Size & Forecast, By Therapeutic Application (USD Billion)
        • Market Size & Forecast, By End User (USD Billion)
    • Europe Oral Drug Delivery Technology Market Size & Forecast (2024-2031), By Country, USD Billion
      • UK
        • Market Size & Forecast, By Dosage Form, (USD Billion)
        • Market Size & Forecast, By Delivery Type (USDze & Forecast, By Therapeutic Application (USD Billion)
        • Market Size & Forecast, By End User (USD Billion)
      • Germany
        • Market Size & Forecast, By Dosage Form, (USD Billion)
        • Market Size & Forecast, By Delivery Type (USD Billion)
        • Market Size & Forecast, By Therapeutic Application (USD Billion)
        • Market Size & Forecast, By End User (USD Billion)
      • France
        • Market Size & Forecast, By Dosage Form, (USD Billion)
        • Market Size & Forecast, By Delivery Type (USD Billion)
        • Market Size & Forecast, By Therapeutic Application (USD Billion)
        • Market Size & Forecast, By End User (USD Billion)
      • Italy
        • Market Size & Forecast, By Dosage Form, (USD Billion)
        • Market Size & Forecast, By Delivery Type (USD Billion)
        • Market Size & Forecast, By Therapeutic Application li>Market Size & Forecast, By End User (USD Billion)
      • Spain
        • Market Size & Forecast, By Dosage Form, (USD Billion)
        • Market Size & Forecast, By Delivery Type (USD Billion)
        • Market Size & Forecast, By Therapeutic Application (USD Billion)
        • Market Size & Forecast, By End User (USD Billion)
      • Rest of Europe
        • Market Size & Forecast, By Dosage Form, (USD Billion)
        • Market Size & Forecast, By Delivery Type (USD Billion)
        • Market Size & Forecast, By Therapeutic Application (USD Billion)
        • Market Size & Forecast, By End User (USD Billion)
    • Asia Pacific (APAC) Oral Drug Delivery Technology Market Size & Forecast (2024-2031), By Country, USD Billion
      • China
        • Market Size & Forecast, By Dosage Form, (USD Billion)
        • Market Size & Forecast, By Delivery Type (USD Billion)
        • Mze & Forecast, By Therapeutic Application (USD Billion)
        • Market Size & Forecast, By End User (USD Billion)
      • Japan
        • Market Size & Forecast, By Dosage Form, (USD Billion)
        • Market Size & Forecast, By Delivery Type (USD Billion)
        • Market Size & Forecast, By Therapeutic Application (USD Billion)
        • Market Size & Forecast, By End User (USD Billion)
      • India
        • Market Size & Forecast, By Dosage Form, (USD Billion)
        • Market Size & Forecast, By Delivery Type (USD Billion)
        • Market Size & Forecast, By Therapeutic Application (USD Billion)
        • Market Size & Forecast, By End User (USD Billion)
      • Rest of Asia Pacific
        • Market Size & Forecast, By Dosage Form, (USD Billion)
        • Market Size & Forecast, By Delivery Type (USD Billion)
        • Market Size & Forecast, By Therapeutic Application (USD Billion
        • Market Size & Forecast, By End User (USD Billion)
    • Latin America (LATAM) Oral Drug Delivery Technology Market Size & Forecast (2024-2031), USD Billion
      • Market Size & Forecast, By Dosage Form, (USD Billion)
      • Market Size & Forecast, By Delivery Type (USD Billion)
      • Market Size & Forecast, By Therapeutic Application (USD Billion)
      • Market Size & Forecast, By End User (USD Billion)
    • Middle East & Africa (MEA) Oral Drug Delivery Technology Market Size & Forecast (2024-2031), USD Billion
      • Market Size & Forecast, By Dosage Form, (USD Billion)
      • Market Size & Forecast, By Delivery Type (USD Billion)
      • Market Size & Forecast, By Therapeutic Application (USD Billion)
      • Market Size & Forecast, By End User (USD Billion)
  1. Competitive Landscape
    • Key Players and their Competitive Positioning
      • Key Player Comparison
      • Segment-wise Player Mapping
      • Market Share Analysis (2025)
      • Company Categorization Matrix
        • Dominants/Leaders
        • New Entrants
        • Emerging Players
        • Innovative Players
      • Key Strategies Assessment, By Player (2023-2026)
        • New Product Launches
        • Partnerships, Agreements, & Collaborations
        • Mergers & Acquisitions
        • Geographic Expansion
  1. Company Profiles*
(Business Overview, Financial Performance**, Products Offered, Recent Developments)
  • Johnson & Johnson
  • GSK plc.
  • Pfizer Inc.
  • AstraZeneca
  • Novartis AG
  • AbbVie Inc.
  • Sanofi
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • Boehringer Ingelheim International GmbH
  • Other Prominent Players
Note: *Indicative list **For listed companies

Related Reports

View All Research Reports